Mariusz S. Wiglusz

Gdansk, PM, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

Appetite measures during ketamine administration in treatment-resistant mood disorders: a naturalistic study.

Appetite measures during ketamine administration in treatment-resistant mood disorders: a naturalistic study.

Journal: Frontiers in nutrition

Published: April 17, 2026

Comparative assessment of stress-related disorders and arterial hypertension burden in Ukrainian refugee women and women staying in Ukraine during the war.

Comparative assessment of stress-related disorders and arterial hypertension burden in Ukrainian refugee women and women staying in Ukraine during the war.

Journal: Kardiologia polska

Published: March 18, 2026

Estrogen metabolites and hydrogen peroxide - Missing elements in the pathophysiology and possible treatment of treatment-resistant depression?

Estrogen metabolites and hydrogen peroxide - Missing elements in the pathophysiology and possible treatment of treatment-resistant depression?

Journal: Redox biology

Published: January 29, 2025

Diversity of central nervous system manifestations in Sjogren's Disease: a case-based review.

Diversity of central nervous system manifestations in Sjogren's Disease: a case-based review.

Journal: Rheumatology international

Published: November 13, 2024

Ketamine and lamotrigine combination in mood disorders-A call for real-world evidence reporting.

Ketamine and lamotrigine combination in mood disorders-A call for real-world evidence reporting.

Journal: Bipolar disorders

Published: July 29, 2024

Intravenous ketamine infusions in patients with depression and Epilepsy: Case series.

Intravenous ketamine infusions in patients with depression and Epilepsy: Case series.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: May 21, 2024

Anhedonia in bipolar depression treated with ketamine.

Anhedonia in bipolar depression treated with ketamine.

Journal: Bipolar disorders

Published: February 04, 2024

Exploring the Relationship between Mood Disorders and Coexisting Health Conditions: The Focus on Nutraceuticals.

Exploring the Relationship between Mood Disorders and Coexisting Health Conditions: The Focus on Nutraceuticals.

Journal: Brain sciences

Published: July 09, 2023

Comment on 'The overlapping relationship among depression, anxiety, and somatic symptom disorder and its impact on the quality of life of people with epilepsy'.

Comment on 'The overlapping relationship among depression, anxiety, and somatic symptom disorder and its impact on the quality of life of people with epilepsy'.

Journal: Therapeutic advances in neurological disorders

Published: May 04, 2023

Comment on 'Characteristics of poisonings involving ketamine in the United States, 2019-2021'.

Comment on 'Characteristics of poisonings involving ketamine in the United States, 2019-2021'.

Journal: Journal of psychopharmacology (Oxford, England)

Published: May 03, 2023

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder.

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder.

Journal: Frontiers in neuroscience

Published: May 01, 2023

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression.

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression.

Journal: Brain sciences

Published: December 30, 2022

Showing 1-12 of 77

Last Updated: 09/26/2026